– Evaluating a Next Generation Anti-CD40L Antibody as a Therapy for Patients with ALS
Time: 11:30 am
day: Day Two AM
Details:
- The rationale for targeting CD40L in patients with ALS
- Results of a pilot study targeting CD40L in patients with ALS
- Looking to the future with targeting CD40L in patients with ALS
